BCM
ULBI icon

BlueCrest Capital Management’s Ultralife ULBI Stock Holding History

BlueCrest Capital Management’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,900
Closed -$163K – 1030
2019
Q1 		$163K Buy
+15,900
New +$143K 0.01% 999
2018
Q2 		– Sell
-10,662
Closed -$107K – 1829
2018
Q1 		$107K Buy
+10,662
New +$82.5K ﹤0.01% 1356

Other funds holding ULBI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BlueCrest Capital Management's ULBI Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Ultralife (ULBI) in Q2 2019, closing a stake of 15,900 shares — an estimated $163K sold.

BlueCrest Capital Management first reported a position in ULBI in Q1 2018 and held it in 2 quarters. The position peaked at $163K in Q1 2019. 35 funds tracked by Wall St. Rank hold ULBI as of Q2 2019.

  • BlueCrest Capital Management reported no remaining Ultralife position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 15,900 Ultralife shares in Q2 2019, an estimated $163K.
  • BlueCrest Capital Management first reported a position in Ultralife in Q1 2018 and held it in 2 quarters.
  • BlueCrest Capital Management's Ultralife position peaked at $163K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Ultralife as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.